Testing effectiveness (Phase 2)Study completedNCT00732498
What this trial is testing
Rituximab, Yttrium Y 90 Ibritumomab Tiuxetan in Patients W/Relapsed Stage II, III, or IV Follicular NHL
Who this might be right for
Lymphoma
University of Arizona 28